Healthcare & Life Sciences

QureBio

United States

series-c-plus

Stage

Investors

About

QureBio develops small molecule therapeutics focusing on oncology and other disease areas, advancing innovative drug candidates primarily in the US market.

Explore QureBio's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.